Secukinumab Persistence in Patients with Psoriatic Arthritis: An Adalimumab-Matched Retrospective Cohort Database Study (FLYWAY)
Patients with PsA showed higher persistence with secukinumab than with adalimumab. Since PsA is a chronic disease that requires long-term treatment, long-term persistence and usefulness should be considered for the treatment choice. Infographic available for this article. INFOGRAPHIC.
Authors
- Toshiaki Mikami
- Hideto Kameda (ORCID: https://orcid.org/0000-0002-4330-5782)
- Akimichi Morita (ORCID: https://orcid.org/0000-0001-8372-3754)
- Hideya Uratsuji (ORCID: https://orcid.org/0000-0003-2811-0474)
- Junna Kiriyama (ORCID: https://orcid.org/0009-0008-2468-5311)
- Kentaro Ishii (ORCID: https://orcid.org/0000-0002-8091-6304)
Institutions
- Toho University (JP)
- Nagoya City University (JP)
- Novartis (Japan) (JP)
- Maruho (Japan) (JP)
- Toranomon Hospital (JP)
Publication Details
- Journal
- Rheumatology and Therapy
- Published
- 2025-03-12
- DOI
- https://doi.org/10.1007/s40744-025-00749-7
- Citations
- 1
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.67